Cargando…
A self antigen reopens the games in pancreatic cancer
We have recently demonstrated that the administration of a plasmid coding for α-enolase can elicit robust immune responses in genetically engineered mice that spontaneously develop pancreatic cancer, resulting in a significant improvement of their survival. This approach provides a springboard for t...
Autores principales: | Cappello, Paola, Novelli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716733/ https://www.ncbi.nlm.nih.gov/pubmed/23894698 http://dx.doi.org/10.4161/onci.24384 |
Ejemplares similares
-
Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma
por: Beatty, Gregory L
Publicado: (2014) -
Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012) -
The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells: Implications for pancreatic cancer-driven immunosuppression
por: Basso, Daniela, et al.
Publicado: (2013) -
The pancreatic cancer microenvironment: an immunologic battleground
por: Pillarisetty, Venu G
Publicado: (2014) -
The dark side of ferroptosis in pancreatic cancer
por: Liu, Jiao, et al.
Publicado: (2021)